
Immunising infants and older people against RSV found to not be cost-effective - HIQA
28.4.2026
0:00
2:54
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.
See omnystudio.com/listener for privacy information.
Weitere Episoden von „Morning Ireland“



Verpasse keine Episode von “Morning Ireland” und abonniere ihn in der kostenlosen GetPodcast App.








